KR101051084B1 - [18f]폴리프라이드의 개선된 제조방법 - Google Patents
[18f]폴리프라이드의 개선된 제조방법 Download PDFInfo
- Publication number
- KR101051084B1 KR101051084B1 KR1020090086354A KR20090086354A KR101051084B1 KR 101051084 B1 KR101051084 B1 KR 101051084B1 KR 1020090086354 A KR1020090086354 A KR 1020090086354A KR 20090086354 A KR20090086354 A KR 20090086354A KR 101051084 B1 KR101051084 B1 KR 101051084B1
- Authority
- KR
- South Korea
- Prior art keywords
- fluorine
- solvent
- polypride
- poly
- ion exchange
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
구분 | 상이동촉매(염기) | 용매(1.0/0.2 ㎖) | 플루오린-18의 회수율(%) |
1 | K2.2.2./K2CO3(5.5/0.5 mg) | CH3CN/H2O | ~18 |
2 | K2.2.2./K2CO3(5.5/1.5 mg) | CH3CN/H2O | ~57 |
3 | K2.2.2./K2CO3(13/3.0 mg) | CH3CN/H2O | >95 |
4 | K2.2.2./K2CO3(11/0.5 mg) | MeOH/H2O | ~88 |
5 | K2.2.2./K2CO3(11/0.8 mg) | MeOH/H2O | >95 |
6 | 40% TBAHCO3 (10 ㎕) | CH3CN/H2O | ~52 |
7 | 40% TBAHCO3 (20 ㎕) | CH3CN/H2O | ~74 |
8 | 40% TBAHCO3 (30 ㎕) | CH3CN/H2O | >95 |
9 | 40% TBAHCO3 (5 ㎕) | MeOH/H2O | ~80 |
10 | 40% TBAHCO3 (10 ㎕) | MeOH/H2O | >95 |
구분 | 상이동촉매(염기) | 용매 (1.0/0.2 ㎖) |
반응시간 (분) |
방사성 수율 (%) |
총 제조시간 (분) |
1 | K2.2.2./K2CO3 (13/3.0 mg) |
CH3CN/H2O | 30 | 26±4.9 | 74±1.2 |
2 | K2.2.2./K2CO3 (11/0.8 mg) |
MeOH/H2O | 30 | 71±1.9 | 74±1.2 |
3 | 40% TBAHCO3 (30 ㎕) | CH3CN/H2O | 30 | 44±4.1 | 74±1.2 |
4 | 40% TBAHCO3 (10 ㎕) | MeOH/H2O | 30 | 71±1.2 | 74±1.2 |
5 | 40% TBAHCO3 (10 ㎕) | MeOH/H2O | 10 | 68±1.6 | 51±1.2 |
Claims (6)
- 폴리머 이온교환 카트리지에 플루오린-18을 흡착시키는 단계(단계 1);플루오린-18이 흡착된 폴리머 이온교환 카트리지에 상이동촉매로서 5.0~25 ㎕의 40% TBAHCO3 또는 K2.2.2./K2CO3(5~25 mg/0.5~3.0 mg), 및 용매로서 알코올/물(1.0/0.2(v/v))의 혼합용매 또는 알코올을 넣어 플루오린-18을 용출시키는 단계(단계 2);상기 용출된 플루오린-18의 용매를 제거한 후, 토실레이트 전구체, 용매로서 CH3CN를 반응기에 넣고 50~120 ℃에서 5~35분 동안 반응시켜 [18F]폴리프라이드 조생성물을 제조하는 단계(단계 3); 및상기 제조된 [18F]폴리프라이드 조생성물을 정제하여 순수한 [18F]폴리프라이드를 제조하는 단계(단계 4)를 포함하는 [18F]폴리프라이드의 자동화 제조방법.
- 제1항에 있어서, 상기 폴리머 이온교환 카트리지는 QMA® 카트리지 또는 Chromafix® PS-HCO3 카트리지인 것을 특징으로 하는 [18F]폴리프라이드의 자동화 제조방법.
- 제1항에 있어서, 상기 단계 2의 알코올은 C1~C6의 직쇄 또는 측쇄 알코올인 것을 특징으로 하는 [18F]폴리프라이드의 자동화 제조방법.
- 제1항에 있어서, 상기 제조방법으로 제조된 [18F]폴리프라이드는 65~75%의 방사화학적 수율을 나타내는 것을 특징으로 하는 [18F]폴리프라이드의 제조방법.
- 제1항에 있어서, 상기 제조방법의 총 제조시간은 40~55분이 소요되는 것을 특징으로 하는 [18F]폴리프라이드의 제조방법.
- 제1항에 있어서, 상기 제조방법은 추가적으로 염기에 민감한 FP-CIT(N-2-fluoropropyl-3-b-(4-iodophenyl)nortropane-2-b-carboxylic acid), FAZA(1-(5-Deoxy-5-fluoro-a-D-arabinofuranosyl)-2-nitroimidazole) 또는 FDDNP(2-(1.1-dicyanopropen-2-yl)-6-(fluoroethyl)methylamino)naphthalene)의 제조에도 적용될 수 있는 것을 특징으로 하는 [18F]폴리프라이드의 제조방법.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090086354A KR101051084B1 (ko) | 2009-09-14 | 2009-09-14 | [18f]폴리프라이드의 개선된 제조방법 |
PCT/KR2010/001351 WO2011030981A1 (en) | 2009-09-14 | 2010-03-04 | Method for preparing [18f]fallypride with low base concentration |
US13/395,841 US8624039B2 (en) | 2009-09-14 | 2010-03-04 | Method for preparing [18F]fallypride with low base concentration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090086354A KR101051084B1 (ko) | 2009-09-14 | 2009-09-14 | [18f]폴리프라이드의 개선된 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110028765A KR20110028765A (ko) | 2011-03-22 |
KR101051084B1 true KR101051084B1 (ko) | 2011-07-21 |
Family
ID=43732622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090086354A KR101051084B1 (ko) | 2009-09-14 | 2009-09-14 | [18f]폴리프라이드의 개선된 제조방법 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8624039B2 (ko) |
KR (1) | KR101051084B1 (ko) |
WO (1) | WO2011030981A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102329359A (zh) * | 2011-07-15 | 2012-01-25 | 无锡江原安迪科分子核医学研究发展有限公司 | 一种制备18f-flt的工艺及其配套试剂盒 |
US10473668B2 (en) * | 2014-06-06 | 2019-11-12 | The Regents Of The University Of California | Self-shielded, benchtop radio chemistry system with a plurality shielded carriers containing a disposable chip cassette |
EP3538161B1 (en) * | 2016-11-08 | 2022-07-27 | The Regents of The University of California | Methods for multi-dose synthesis of [f-18]fddnp for clinical settings |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0308407D0 (en) | 2003-04-11 | 2003-05-21 | Amersham Plc | Method of obtaining 68 GA |
CN101157649A (zh) | 2007-10-23 | 2008-04-09 | 江苏省原子医学研究所 | 18F-Fallypride自动化合成的方法 |
CN100569748C (zh) | 2007-10-23 | 2009-12-16 | 江苏省原子医学研究所 | 一种18F-Fallypride标记前体化合物的纯化方法 |
-
2009
- 2009-09-14 KR KR1020090086354A patent/KR101051084B1/ko active IP Right Grant
-
2010
- 2010-03-04 WO PCT/KR2010/001351 patent/WO2011030981A1/en active Application Filing
- 2010-03-04 US US13/395,841 patent/US8624039B2/en active Active
Non-Patent Citations (2)
Title |
---|
Current Radiopharmaceuticals, 2009.January, 2(1), 49-55 |
Nuclear Medicine and biology, 1995, 22(3), 283-296 |
Also Published As
Publication number | Publication date |
---|---|
WO2011030981A1 (en) | 2011-03-17 |
US20120178920A1 (en) | 2012-07-12 |
KR20110028765A (ko) | 2011-03-22 |
US8624039B2 (en) | 2014-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | One-step high-radiochemical-yield synthesis of [18F] FP-CIT using a protic solvent system | |
Moon et al. | Highly efficient production of [18F] fallypride using small amounts of base concentration | |
US10584078B2 (en) | Dual run cassette for the synthesis of 18F-labelled compounds | |
WO2006133732A1 (en) | Process for synthesizing labelled compounds | |
Kim et al. | Rapid synthesis of [18F] FDG without an evaporation step using an ionic liquid | |
US8968701B2 (en) | Usage of low to medium-pressure liquid chromatography for the purification of radiotracers | |
US9061996B2 (en) | Solid phase extraction method | |
JP2010525931A (ja) | 分離法 | |
KR101051084B1 (ko) | [18f]폴리프라이드의 개선된 제조방법 | |
Luurtsema et al. | Fully automated high yield synthesis of (R)‐and (S)‐[11C] verapamil for measuring P‐glycoprotein function with positron emission tomography | |
Lee et al. | New automated synthesis of [18F] FP-CIT with base amount control affording high and stable radiochemical yield: a 1.5-year production report | |
Hamacher et al. | No-carrier-added nucleophilic 18F-labelling in an electrochemical cell exemplified by the routine production of [18F] altanserin | |
Peng et al. | An automated synthesis of N, N-dimethyl-2-(2-amino-4-[18F] fluorophenylthio) benzylamine (4-[18F]-ADAM) for imaging serotonin transporters | |
Sarasamkan et al. | Radiosynthesis of (S)-[18F] T1: The first PET radioligand for molecular imaging of α3β4 nicotinic acetylcholine receptors | |
Teodoro et al. | A high-yield automated radiosynthesis of the alpha-7 nicotinic receptor radioligand [18F] NS10743 | |
Kirjavainen et al. | 18F-labeled norepinephrine transporter tracer [18F] NS12137: radiosynthesis and preclinical evaluation | |
DK2880005T3 (en) | RADIO FLUOR RING PROCEDURE | |
Jarkas et al. | Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography | |
CN107001213B (zh) | 具有氟化脂肪族基团的有机化合物的制备方法及纯化方法 | |
Yue et al. | Automated production of 1-(2-[18F] fluoroethyl)-l-tryptophan for imaging of tryptophan metabolism | |
JP7288261B2 (ja) | 分離装置、分離方法、ri分離精製システムおよびri分離精製方法 | |
EP3538161B1 (en) | Methods for multi-dose synthesis of [f-18]fddnp for clinical settings | |
Fedorova et al. | Automated Synthesis of [18 F] Fluoromethylcholine for Positron-Emission Tomography Imaging | |
TWI504412B (zh) | f正子放射性同位素標誌之血清素運轉器造影劑的製造方法 | |
Li et al. | Synthesis and Biological Evaluation of 10‐11C‐Dihydrotetrabenazine as a Vesicular Monoamine Transporter 2 Radioligand |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140707 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150629 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160204 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170626 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180620 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190625 Year of fee payment: 9 |